JA Bolognese

Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men.

Georges Copinschi, Anne Van Onderbergen, Mireille L’Hermite‐Balériaux et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 76 citations · Full text

Human Growth, Pharmacotherapy, Gastrointestinal Peptide Hormone +16

Oral Administration of the Growth Hormone Secretagogue MK-677 Increases Markers of Bone Turnover in Healthy and Functionally Impaired Elderly Adults

M. Gail Murphy, Mark A. Bach, D. Plotkin et al. · Journal of Bone and Mineral Research · 1999 · 48 citations · Full text

Bone Disease, Gh Secretagogue, Urology +14

Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation.

DG Sciberras, Goldenberg Mm, JA Bolognese et al. · British Journal of Clinical Pharmacology · 1987 · 31 citations · Full text

Acute Pain, Intradermal Injection, Pain Medicine +20

Lisinopril: dose‐peak effect relationship in essential hypertension.

VJ Cirillo, HJ Gomez, Juha Salonen et al. · British Journal of Clinical Pharmacology · 1988 · 24 citations · Full text

Effective dose range of enalapril in mild to moderate essential hypertension.

Robert Bergstrand, Hans Herlitz, Sara Ellinor Johansson et al. · British Journal of Clinical Pharmacology · 1985 · 19 citations · Full text